Chronic Obstructive Pulmonary Disease (COPD) Management Update – Nurse, Nurse Practitioner

  Price  $6.95

  Credits  1.5

Clear


Format
Chronic Obstructive Pulmonary Disease (COPD) was the fourth leading cause of death in the United States in 2018 and a significant cause of illness and disability. It affects more than 15 million Americans, though prevalence varies considerably by state, from 3.7% of adults in Hawaii to 13.6% of adults in West Virginia. Over the next 20 years, COPD is projected to incur direct medical costs of over $800 billion in the U.S. alone. The most widely utilized guidelines related to the diagnosis and treatment of COPD have been developed by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), the American Thoracic Society (ATS), and a collaboration between the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society (ERS). Though the majority of patients with COPD in the U.S. are cared for by primary care clinicians, the lack of COPD-related knowledge remains a significant barrier to the care of this patient population. Accordingly, familiarity with the standards of care reviewed in this article will help primary care clinicians optimize the care of patients with stable COPD.
$6.95

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Nurse

Nurse Practitioner

Author

Jonathan Hughes
PharmD, BCPS, BCACP
Jessica Wallace
PharmD, BCPS
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Nurse

Nurse

  • Classify COPD patients using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD assessment tool
  • Identify drug classes used to treat stable COPD including the therapeutic benefits, adverse effects, and key counseling points
  • Recall first-line therapy for a patient with stable COPD based on GOLD ABCD group classification

Nurse Practitioner

Nurse Practitioner

  • Classify COPD patients using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) ABCD assessment tool
  • Identify drug classes used to treat stable COPD including the therapeutic benefits, adverse effects, and key counseling points
  • Recall first-line therapy for a patient with stable COPD based on GOLD ABCD group classification

Course Accreditation

  • Activity Type:
    Knowledge
  • CE Broker
    915237
  • Universal Activity Number:
    Nurse : 0798-0000-22-148-H01
    Nurse Practitioner : 0798-0000-22-148-H01
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

Credit for this program is issued by passing the final test hosted at www.RxConsultant.com with a score of 70% or higher.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.